Umbilical Cord Blood Transplantation
Post-transplant lymphoproliferative disorder occurs early after UCBT in children
Published in Blood Weekly, May 18th, 2006
According to a study from the United States, "Reported are 7 cases of post-transplant lymphoproliferative disorder (PTLD) arising in children who received umbilical cord blood transplantation (UCBT). There were 4 females and 3 males with a median age of 3 years (range, 1-16 years).
"All 7 patients received UCBT, including 1 patient who received multiple units and 1 transplanted under nonmyeloablative condition. The time interval from UCBT to PTLD averaged 4 months (range, 2 weeks to 9 months)."
"Patients typically...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-05-18)
More Articles from Blood Weekly
- Angiology
Endothelial cell progenitors display differential healing activities - Blood Safety
West Nile virus targets monocytes-macrophages after blood transfusion - Tissue Engineering
Decellularized heart valve matrix attracts inflammatory cells and induces platelet activation - West Nile Virus
West Nile virus blood donor screening can be used to monitor seasonal incidence - Acute Myeloid Leukemia
Myeloid HSCs with minimal lymphopoietic potential may be AML transformation site - Adverse Drug Reaction
Children with cancer experienced decrease in motor performance, independent of vincristine - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
